CJC1295 without DAC

CJC-1295 without DAC – Short-Acting GHRH Analogue Research Peptide

CJC-1295 without DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue designed to engage GHRH receptors and stimulate the release of growth hormone (GH) in in-vitro systems. Unlike the DAC-modified variant, this peptide exhibits a shorter half-life, enabling investigators to examine natural, pulsatile GH secretion patterns in biochemical and endocrinological in-vitro models.

This reagent is manufactured under strict laboratory standards and verified by High-Performance Liquid Chromatography (HPLC) to a purity of ≥99%. It is presented as a stable lyophilized powder formulated for use in assay development and in-vitro research workflows.

Key Specifications

• Name: CJC-1295 without DAC
• Molecular Formula: C152H252N44O42
• Molecular Weight: ≈ 3368.9 Da
• Form: Lyophilized Powder
• Purity: ≥99% (HPLC verified)
• Storage: Store refrigerated, protected from light and moisture
• Shelf life: Sealed lyophilizate. Shelf life 24 months from manufacture.

Research Applications

• Studied in the context of physiological GH secretion patterns in in-vitro settings.
• Referenced in investigations of GHRH receptor dynamics and growth hormone regulation.
• Used as a reagent for modelling pulsatile endocrine responses in cell-based assays.
• Supplied in a lyophilized format suitable for stable long-term storage and repeatable experimental use.

A batch-specific Certificate of Analysis (CoA) is available on request and accompanies every order.